- Home
- GHI vs SCPH Comparison
GHI vs SCPH Comparison
Compare GHI & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHI
- SCPH
- Stock Information
- Founded
- GHI 1998
- SCPH 2013
- Country
- GHI United States
- SCPH United States
- Employees
- GHI N/A
- SCPH N/A
- Industry
- GHI Finance: Consumer Services
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- GHI Finance
- SCPH Health Care
- Exchange
- GHI Nasdaq
- SCPH Nasdaq
- Market Cap
- GHI 254.1M
- SCPH 299.0M
- IPO Year
- GHI N/A
- SCPH 2017
- Fundamental
- Price
- GHI $10.77
- SCPH $5.63
- Analyst Decision
- GHI Strong Buy
- SCPH Buy
- Analyst Count
- GHI 4
- SCPH 3
- Target Price
- GHI $14.88
- SCPH $12.00
- AVG Volume (30 Days)
- GHI 51.9K
- SCPH 2.3M
- Earning Date
- GHI 11-05-2025
- SCPH 11-12-2025
- Dividend Yield
- GHI 13.72%
- SCPH N/A
- EPS Growth
- GHI N/A
- SCPH N/A
- EPS
- GHI N/A
- SCPH N/A
- Revenue
- GHI $27,326,828.00
- SCPH $49,969,000.00
- Revenue This Year
- GHI $228.92
- SCPH $108.95
- Revenue Next Year
- GHI $4.27
- SCPH $78.30
- P/E Ratio
- GHI N/A
- SCPH N/A
- Revenue Growth
- GHI N/A
- SCPH 107.79
- 52 Week Low
- GHI $10.12
- SCPH $1.94
- 52 Week High
- GHI $14.51
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- GHI 48.31
- SCPH 64.37
- Support Level
- GHI $10.65
- SCPH $4.33
- Resistance Level
- GHI $10.88
- SCPH $5.62
- Average True Range (ATR)
- GHI 0.21
- SCPH 0.05
- MACD
- GHI 0.01
- SCPH 0.01
- Stochastic Oscillator
- GHI 50.00
- SCPH 93.75
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.